ALNOV:EPA
Novacyt SA
0,44 €
arrow_upward
+1,37%(+0,0060) 1D
29 қаз., 17:35:13 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,44 €
High
0,45 €
Low
0,44 €
Mkt. cap
30,77 млн
Avg. vol.
196,69 м.
Volume
35,97 мың
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
Open
0,44 €
High
0,45 €
Low
0,44 €
Mkt. cap
30,77 млн
Avg. vol.
196,69 м.
Volume
35,97 мың
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
News stories
From web sources and news partners
Stocktwits
·
15 минут бұрын
Nasdaq 100 Futures Dip On Weak Intel, Amazon Earnings With Bloated Capex Worries Weighing On Sentiment — AMZN, INTC, SBUX, PLTR, ASTS In Focus
Yahoo Finance
·
51 минут бұрын
20 Years of S&P 500 History Show: This Simple Strategy Is Only 8.3% Less Than "Perfect"
Investor's Business Daily
·
1 сағат бұрын
Nasdaq Dives As Alphabet Has Worst Day Ever. But Note These Stock Market Silver Linings.
Investing.com
·
2 сағат бұрын
Narragansett Bancorp sets Nov. 2 for IPO, Nasdaq debut
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA